Related Experiment Videos
Continuous propofol anaesthesia for patients with myotonic dystrophy
M Bennun1, B Goldstein, Y Finkelstein
1Department of Anaesthesiology and Critical Care Medicine, Meir Hospital, Kfar Saba, Sackler School of Medicine, Tel-Aviv University, Israel.
British Journal of Anaesthesia
|December 5, 2000
Summary
Anesthesia using propofol infusion and fentanyl is safe for patients with myotonic dystrophy. This technique led to smooth recoveries without significant respiratory complications in young patients undergoing surgery.
Area of Science:
- Anesthesiology
- Genetics
- Neurology
Background:
- Myotonic dystrophy presents anesthetic challenges due to muscular and extramuscular involvement.
- Managing anesthesia in myotonic dystrophy patients requires careful consideration of potential complications.
Purpose of the Study:
- To evaluate the safety and efficacy of continuous propofol infusion combined with fentanyl, atracurium, and N2O in young myotonic dystrophy patients.
Main Methods:
- Thirteen patients with myotonic dystrophy (median age 21 years) received anesthesia with continuous propofol infusion, fentanyl, atracurium, and N2O for peripheral surgery.
- Hemodynamic stability, intraoperative reactions, recovery, vital capacity, SpO2, and postoperative complications were monitored.
Main Results:
- No exaggerated reactions or hemodynamic instability were observed during anesthesia.
- Recovery was smooth and rapid, with no muscular hypertonia or shivering.
- A significant decrease in postoperative vital capacity was noted, but no change in SpO2 or perioperative respiratory complications occurred.
- Only two patients experienced nausea and vomiting.
Conclusions:
- Continuous propofol infusion and fentanyl provide a successful anesthetic technique for young myotonic dystrophy patients undergoing peripheral surgery.
- This anesthetic combination appears safe, with minimal adverse effects and good recovery profiles.